Top Markets
#1 EXOD EXOD +56.80%
#2 CoW Protocol CoW Protocol +51.10%
#3 Cysic Cysic +41.67%
#4 Glidr Glidr +36.41%
#5 Walrus Walrus +33.72%
#6 Humanity Humanity +25.21%
#7 Tutorial Tutorial +16.37%
#8 Codatta Codatta +15.99%
#9 Enso Enso +15.97%
#10 Ribbita by Virtuals Ribbita by Virtuals +14.44%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Rank in Stocks #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Share Price
$0.6
Last synced: 2024-08-14
Market Cap
$2.09M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
SG
Trade ASLAN Pharmaceuticals Limited (ASLN)

Category

Healthcare
Operating Margin for ASLAN Pharmaceuticals Limited (ASLN)
Operating Margin as of August 2026 TTM: -364.46%
According to ASLAN Pharmaceuticals Limited latest financial reports and stock price the company's current Operating Margin (TTM) is -364.46%. At the end of 2022 the company had an Operating Margin of 0.00%.
Operating Margin history for ASLAN Pharmaceuticals Limited from 2014 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) -364.46% 0.00%
2023 -364.46% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% -100.00%
2019 -1,519.30% 0.00%
2018 0.00% 0.00%
2017 0.00% -100.00%
2016 -75.34% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -100.11%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -100.08%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -100.09%
BE
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.